Search Page

1

Cite

Share

Correspondence to European Heart Journal-Quality of Care and Clinical Outcomes in response to letter by Dalal H. et al.

Thomas M, Jones PG, Cohen DJ, Arnold SV, Magnuson EA, Thourani VH, Fonarow GC, Sandhu AT, Spertus JA. Thomas M, et al. Eur Heart J Qual Care Clin Outcomes. 2021 Jul 21;7(4):e8. doi: 10.1093/ehjqcco/qcab034. Eur Heart J Qual Care Clin Outcomes. 2021. PMID: 33914883 No abstract available.

Cite

Share

2

Cite

Share

Cardiovascular risk factors, cardiovascular disease, and COVID-19: an umbrella review of systematic reviews.

Harrison SL, Buckley BJR, Rivera-Caravaca JM, Zhang J, Lip GYH. Harrison SL, et al. Eur Heart J Qual Care Clin Outcomes. 2021 Jul 21;7(4):330-339. doi: 10.1093/ehjqcco/qcab029. Eur Heart J Qual Care Clin Outcomes. 2021. PMID: 34107535 Free PMC article. Review.

Cite

Share

3

Cite

Share

Corrigendum.

[No authors listed] [No authors listed] Eur Heart J Qual Care Clin Outcomes. 2020 Jan 1;6(1):91. doi: 10.1093/ehjqcco/qcz060. Eur Heart J Qual Care Clin Outcomes. 2020. PMID: 31697359 No abstract available.

Cite

Share

4

Cite

Share

Medical treatment of heart failure with reduced ejection fraction: the dawn of a new era of personalized treatment?

Ameri P, Bertero E, Maack C, Teerlink JR, Rosano G, Metra M. Ameri P, et al. Eur Heart J Cardiovasc Pharmacother. 2021 Nov 3;7(6):539-546. doi: 10.1093/ehjcvp/pvab033. Eur Heart J Cardiovasc Pharmacother. 2021. PMID: 34037742 Review.

Cite

Share

5

Cite

Share

Correspondence to European Heart Journal-Quality of Care and Clinical Outcomes in response to paper by Thomas, M. et al. 2021: Predicting the EQ-5D from the Kansas City Cardiomyopathy Questionnaire (KCCQ) in patients with heart failures.

Dalal H, Taylor RS, Cleland JG. Dalal H, et al. Eur Heart J Qual Care Clin Outcomes. 2021 Jul 21;7(4):e7. doi: 10.1093/ehjqcco/qcab033. Eur Heart J Qual Care Clin Outcomes. 2021. PMID: 33914892 Free PMC article. No abstract available.

Cite

Share

6

Cite

Share

New York Heart Association (NYHA) classification in adults with congenital heart disease: relation to objective measures of exercise and outcome.

Bredy C, Ministeri M, Kempny A, Alonso-Gonzalez R, Swan L, Uebing A, Diller GP, Gatzoulis MA, Dimopoulos K. Bredy C, et al. Eur Heart J Qual Care Clin Outcomes. 2018 Jan 1;4(1):51-58. doi: 10.1093/ehjqcco/qcx031. Eur Heart J Qual Care Clin Outcomes. 2018. PMID: 28950356 Free article.

Cite

Share

7

Cite

Share

Comparison of dabigatran, rivaroxaban, and apixaban for effectiveness and safety in atrial fibrillation: a nationwide cohort study.

Rutherford OW, Jonasson C, Ghanima W, Söderdahl F, Halvorsen S. Rutherford OW, et al. Eur Heart J Cardiovasc Pharmacother. 2020 Apr 1;6(2):75-85. doi: 10.1093/ehjcvp/pvz086. Eur Heart J Cardiovasc Pharmacother. 2020. PMID: 31942972 Free PMC article.

Cite

Share

8

Cite

Share

Corrigendum.

[No authors listed] [No authors listed] Eur Heart J Qual Care Clin Outcomes. 2020 Apr 1;6(2):180. doi: 10.1093/ehjqcco/qcaa014. Eur Heart J Qual Care Clin Outcomes. 2020. PMID: 32091088 Free PMC article. No abstract available.

Cite

Share

9

Cite

Share

Edoxaban for stroke prevention in atrial fibrillation in routine clinical care: 1-year follow-up of the prospective observational ETNA-AF-Europe study.

de Groot JR, Weiss TW, Kelly P, Monteiro P, Deharo JC, de Asmundis C, López-de-Sá E, Waltenberger J, Steffel J, Levy P, Bakhai A, Zierhut W, Laeis P, Manu MC, Reimitz PE, De Caterina R, Kirchhof P. de Groot JR, et al. Eur Heart J Cardiovasc Pharmacother. 2021 Apr 9;7(FI1):f30-f39. doi: 10.1093/ehjcvp/pvaa079. Eur Heart J Cardiovasc Pharmacother. 2021. PMID: 32790837 Free PMC article.

Cite

Share

10

Cite

Share

The impact of the COVID-19 pandemic on the care and management of patients with acute cardiovascular disease: a systematic review.

Kiss P, Carcel C, Hockham C, Peters SAE. Kiss P, et al. Eur Heart J Qual Care Clin Outcomes. 2021 Jan 25;7(1):18-27. doi: 10.1093/ehjqcco/qcaa084. Eur Heart J Qual Care Clin Outcomes. 2021. PMID: 33151274 Free PMC article.

Cite

Share